Daptomycin
Back to searchMolecule Structure
Scientific Name
Daptomycin
Brand Name(s)
Cubicin, Cubicin rf, Daptomycin
Company Owner(s)
Sagent Pharmaceuticals Inc, Be Pharmaceuticals Ag, Meitheal Pharmaceuticals Inc, Cubist Pharmaceuticals Llc, Hospira Inc, Fresenius Kabi Usa Llc, Xellia Pharmaceuticals Aps, Dr Reddys Laboratories Ltd, Qilu Pharmaceutical Co Ltd, Jiangsu Hengrui Medicine Co Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cell membrane | SUBCELLULAR | INHIBITOR | CHEMBL2364031 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL28102 | |
| PubChem: Thomson Pharma | 14890837 | 14939862 |
| PubChem | 16134395 | |
| EPA CompTox Dashboard | DTXSID1041009 | |
| Metabolights | MTBLC600103 | |
| ChemicalBook | CB8855073 | |
| Guide to Pharmacology | 10904 | |
| rxnorm | DAPTOMYCIN | CUBICIN |
| ChEBI | 600103 |
